IP Library Patent Application 13141962
Patent Application
App. No. 13/141,962

Compositions and Methods for Treating Hyperpigmentation

Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US None
App. No.
13/141,962
Abstract

This invention provides compositions and methods for reducing hyperpigmentation. In preferred embodiments, the compositions are topical compositions that contain kojic acid and a carrier molecule for enhancing the transdermal penetration of kojic acid. This invention also provides kits for treating hyperpigmentation.

Claims (20)

1 . A topical composition comprising

a skin lightening agent, and

a positively charged carrier molecule comprising a positively charged backbone and a plurality of efficiency groups attached thereto.

2 . The topical composition according to claim 1 , wherein the skin-lightening agent is selected from the group consisting of kojic acid, derivative of kojic acid, azelaic acid, ascorbic acid, tretinoin (Retinol), topical glucocorticoids, linoleic acid, niacinimide, 4-t-butyl catechol, tranexamic acid, and licorice extract.

3 . The topical composition according to claim 2 , wherein the skin-lightening agent is kojic acid.

4 . The topical composition according to claim 1 , wherein the positively charged backbone is a polyamino acid or a polyalkyleneimine.

5 . The topical composition according to claim 4 , wherein the polyamino acid is selected from the group consisting of polylysine, polyarginine, polyhistidine, and polyornithine.

6 . The topical composition according to claim 1 , wherein efficiency groups are amino acid sequences selected from the group consisting of -(gly) n1 -(arg) n2 (SEQ ID NO: 1), HIV-TAT or fragments thereof, or Antennapedia PTD or a fragment thereof, (gly) p -RGRDDRRQRRR-(gly) q (SEQ ID NO: 2), (gly) p -YGRKKRRQRRR-(gly) q (SEQ ID NO: 3), and (gly) p -RKKRRQRRR-(gly) q (SEQ ID NO: 4),

wherein the subscript n1 is an integer of from 0 to 20 and the subscript n2 is independently an odd integer of from about 5 to about 25; and

wherein the subscripts p and q are each independently an integer of from 0 to 20.

7 . A method of reducing pigmentation in skin, the method comprising

identifying a region of skin in need of treatment;

applying a topical composition to the region of skin in need of treatment, the topical composition comprising a skin-lightening agent and a positively charged carrier molecule, the positively charged carrier molecule comprising a positively charged backbone and a efficiency groups attached thereto.

8 . The method according to claim 7 , wherein the skin-lightening agent is selected from the group consisting of kojic acid, derivative of kojic acid, azelaic acid, ascorbic acid, tretinoin (Retinol), topical glucocorticoids, linoleic acid, niacinimide, 4-t-butyl catechol, tranexamic acid, and licorice extract.

9 . The method according to claim 8 , wherein the skin-lightening agent is kojic acid.

10 . The method according to claim 7 , wherein the positively charged backbone is a polyamino acid or a polyalkyleneimine.

11 . The method according to claim 10 , wherein the polyamino acid is selected from the group consisting of polylysine, polyarginine, polyhistidine, and polyornithine.

12 . The method according to claim 7 , wherein efficiency groups are amino acid sequences selected from the group consisting of -(gly) n1 -(arg) n2 (SEQ ID NO: 1), HIV-TAT or fragments thereof, or Antennapedia PTD or a fragment thereof, (gly) p -RGRDDRRQRRR-(gly) q (SEQ ID NO: 2), (gly) p -YGRKKRRQRRR-(gly) q (SEQ ID NO: 3), and (gly) p -RKKRRQRRR-(gly) 9 (SEQ ID NO: 4),

wherein the subscript n1 is an integer of from 0 to 20 and the subscript n2 is independently an odd integer of from about 5 to about 25; and

wherein the subscripts p and q are each independently an integer of from 0 to 20.

Assignments (3)
RELEASE OF SECURITY INTEREST Recorded Sep 27, 2019
From: HERCULES CAPITAL, INC. (F/K/A HERCULES TECHNOLOGY GROWTH CAPITAL, INC.)
To: REVANCE THERAPEUTICS, INC.
Reel/Frame 050565/0300 →
SECURITY AGREEMENT Recorded Sep 22, 2011
From: REVANCE THERAPEUTICS, INC.
To: HERCULES TECHNOLOGY GROWTH CAPITAL, INC.
Reel/Frame 026953/0726 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jul 19, 2011
From: WAUGH, JACOB M.
To: REVANCE THERAPEUTICS, INC.
Reel/Frame 026612/0312 →